Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Jacob D.

SEC · Aug 28 07:45

Summary by Futu AI

Jacob D. Cohen, CEO of Mangoceuticals, completed a transaction involving the company's common stock on August 26, 2024. The action, classified as a bona fide gift, consisted of both acquiring and disposing of 800,000 shares at no cost. Following the transaction, Cohen's direct holdings in Mangoceuticals common stock amounted to 9,075,000 shares.

Helpful

Not Helpful

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Mangoceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Cohen Jacob D.

Summary by Futu AI

Risk Disclaimer